Access Bio, Inc.

₩1,832As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:950130Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (10.33%)
Div yield 44.92%
ROE (19.37%)
Medical Devices
Beta (5Y) 0.47
PE TTM —
TSR TTM (53.09%)
Mkt cap ₩64.44B
ROIC (26.37%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,903
3.89%
(57.67%)
Sell 0|0|11|3|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
30.56
33.58
32.23
35.11
21.66%
21.68%
8.67%
17.99%
Revenue₩B
3.910
3.998
4.045
4.150
6.42%
11.02%
12.98%
11.74%
Peers (US$47.51M)
Cap (US$)
PE
46.47M
6.569x
45.04M
9.708x
47.93M
—
Capital
TTM
5Y
10Y
Leveragex
1.593
0.162
0.100
EBIT/Intx
1.161
0.466
0.417
Own earn%
113.34
(75.16)
(61.79)
Sh yield%
16.08
8.44
8.51
Owners
Insiders/Inst%
0.36
75.74
Short interest%
0.70
SBC / revenue%
1.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
18–26
$1 testx
3.4
Incr. ROIC%
11